We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Discovery of 4,6‐bis(2‐((E)‐benzylidene)hydrazinyl)pyrimidin‐2‐Amine with Antibiotic Activity.
- Authors
Russell, Cecilia C.; Stevens, Andrew; Young, Kelly A.; Baker, Jennifer R.; McCluskey, Siobhann N.; Khazandi, Manouchehr; Pi, Hongfei; Ogunniyi, Abiodun; Page, Stephen W.; Trott, Darren J.; McCluskey, Adam
- Abstract
Robenidine (E)‐N′‐((E)‐1‐(4‐chlorophenyl)ethylidene)‐2‐(1‐(4‐chlorophenyl)ethylidene)hydrazine‐1‐carboximidhydrazide displays methicillin‐resistant Staphyoccoccus aureus (MRSA) and vancomycin‐resistant Enterococci (VRE) MICs of 2 μg mL−1. Herein we describe the structure‐activity relationship development of a novel series of guanidine to 2‐aminopyrimidine isosteres that ameliorate the low levels of mammalian cytotoxicity in the lead compound while retaining good antibiotic activity. Removal of the 2‐NH2 pyrimidine moiety renders these analogues inactive. Introduction of a central 2‐NH2 triazine moiety saw a 10‐fold activity reduction. Phenyl to cyclohexyl isosteres were inactive. The 4‐BrPh and 4‐CH3Ph with MIC values of 2 and 4 μg mL−1, against MRSA and VRE respectively, are promising candidates for future development.
- Subjects
ANTIBIOTICS; STRUCTURE-activity relationships; LEAD compounds; GUANIDINES; ENTEROCOCCUS
- Publication
ChemistryOpen, 2019, Vol 8, Issue 7, p896
- ISSN
2191-1363
- Publication type
Article
- DOI
10.1002/open.201800241